# A Combined Single and Multiple Ascending Dose Study of ASP6858 in Healthy Subjects

> **NCT02359032** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Europe B.V.** · enrollment: 88 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** ASP6858
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02359032
- **Lead sponsor:** Astellas Pharma Europe B.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2016-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02359032

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02359032, "A Combined Single and Multiple Ascending Dose Study of ASP6858 in Healthy Subjects". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02359032. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*